NIH-funded research Fellowship grant

Understanding how Neuritin-1 helps protect the brain from Alzheimer's disease

Official title: Defining the Neuroprotective Mechanisms of Neuritin-1 in Cognitive Resilience to Alzheimer's Disease

Funded at University of Alabama at Birmingham · NIH-10900324 · Data updated 2026-11-12

This study is looking at how a protein called Neuritin-1 might help keep the brains of people with Alzheimer's disease functioning well, even when there are signs of the disease, and it could lead to new ways to support brain health as we age.

More s Disease research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startJuly 1, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$40,264
NIH project number1F31AG084195-01A1
Project IDNIH-10900324 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults aged 65 and over, particularly those showing early signs of Alzheimer's disease or cognitive decline.

Less likely to help

Patients under 65 years of age or those without any signs of cognitive impairment may not benefit from this research.

What this research studies

This research investigates the role of Neuritin-1 in promoting cognitive resilience in individuals with Alzheimer's disease (AD). By analyzing proteins associated with cognitive resilience, the study aims to uncover mechanisms that protect older adults from dementia despite the presence of AD pathology. The approach involves advanced mass spectrometry techniques to identify and validate proteins that may contribute to maintaining cognitive function. This research could lead to new therapeutic strategies for enhancing brain health in aging populations.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help preserve cognitive function in individuals at risk for Alzheimer's disease.

How similar studies have gone: Previous research has shown promise in identifying neuroprotective mechanisms in Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Pugh, Derian — University of Alabama at Birmingham
  • Study coordinator: Pugh, Derian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.